80% of Americans oppose transgender surgeries on minors

They also oppose the use of puberty blocking drugs that can cause infertility.

Eight out of ten Americans oppose sex change surgery or the use of puberty blocking drugs on minors before they reach legal age. According to a survey by Convention of States Action and The Trafalgar Group, 78.7% believe that minors should wait. The president of Convention of States Action, Mark Meckler, opposed the idea that minors with gender dysphoria disorder should be able to have surgery before 18.

The idea that young people have to be 16 to drive, 18 to vote, and 21 to drink, and yet can undergo life-altering medical procedures in middle school defies common sense, and the American people see that clearly.

96.8% of Republican Party supporters and 84.6% of independents are against sex changes in minors. More than half of Democrats (53.2%) oppose gender reassignment surgeries on minors too.

Seven out of ten Hispanics oppose the idea that minors should undergo surgery to change their sex. Meanwhile, 100% of Asians, 80.6% of blacks, 78.4% of whites and 80.2% of respondents of unspecified ethnicities agree with the Hispanic community.

Reuters published that between 2019 and 2021, 776 mastectomies and 56 genital surgeries were performed on patients aged 13 to 17 who identified as transgender.

How do puberty blocking drugs work?

Children who are considered transgender begin taking prescription puberty blocking drugs (GnRH agonists), "pause buttons" meant to treat precocious puberty in young children. These drugs can cause minors to become infertile and not achieve sexual satisfaction, as stated by Dr. Marci Bowers.

Endocrinologist Dr. Mike Laidlaw stated that, with GnRH agonists, sex hormone levels are reduced, so puberty stops:

If the medication is taken during adolescence, then the low testosterone and estrogen levels that result will stop puberty for the male and the female respectively.

Regarding males and females, Dr. Laidlaw explained how puberty-blocking drugs work in each sex:

In gender-affirmative therapy for the male body, it may be used to block testosterone release while the person simultaneously takes estrogen. The result in the male will be very low levels of testosterone. This then allows estrogen to become the primary sex hormone of the body. As for females who have already gone through puberty, the medication will result in very low estrogen levels. The medication will also stop menstrual cycles. It appears to be used in females who are transitioning for this purpose, to stop menstrual function, probably as a ‘bridge’ to testosterone.